48 Results

People

  1. Castro-Malaspina
    Castro-Malaspina
  2. Giralt
    Giralt
  3. O'Reilly
    O'Reilly
  4. Papadopoulos
    Papadopoulos
  5. Childs
    Childs
  6. Perales
    Perales
  7. Young
    Young
  8. Landau
    Landau
  9. Shah
    Shah
  10. Gillio
    Gillio

Groups

  1. Bone Marrow Transplant (48)
  2. Center for Hematologic Malignancies (48)
  3. Department of Medicine (48)
  4. Hematologic Malignancies, Division of (48)
  5. Survivorship Research (19)
  6. Sloan Kettering Institute Faculty (15)
  7. GSK Faculty (13)
  8. Pediatrics, Department of (13)
  9. Immunology Program Faculty (11)
  10. Stem Cell Transplantation and Cellular Therapy Service (11)
  1. "Bone Marrow Transplant"
  2. "Department of Medicine"
  3. "Hematologic Malignancies, Division of"
  4. "Elsevier Science, Inc."
Formats
  1. Meeting Abstract (26)
  2. Journal Article (17)
  3. Review (3)
  4. Correspondence (1)
  5. Guidelines (1)
Groups
  1. Bone Marrow Transplant (48)
  2. Center for Hematologic Malignancies (48)
  3. Department of Medicine (48)
  4. Hematologic Malignancies, Division of (48)
  5. Survivorship Research (19)
  6. Sloan Kettering Institute Faculty (15)

More Groups

People
  1. Hugo Castro-Malaspina (11)
  2. Sergio Giralt (11)
  3. Esperanza Papadopoulos (9)
  4. Richard O'Reilly (9)
  5. Barrett Childs (7)
  6. James Young (7)

More People

Years
  1. 2024 (4)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (4)
  5. 2020 (3)
  6. 2019 (4)

More Years

Publications
  1. Experimental Hematology (16)
  2. The Lancet Haematology (9)
  3. Lancet Oncology (5)
  4. Journal of the American College of Cardiology (4)
  5. Value in Health (4)
  6. International Journal of Infectious Diseases (2)

More Publications

Publishers
  1. Elsevier Science, Inc. (48)

Results (48)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Urgent need: Evidence-based use of donor lymphocyte infusions
    Correspondence

    Boelens, J. J.; Scordo, M.
    The Lancet Haematology (2024)

    Fulltext@MSK | Save
  • Immune effector cell-associated haematotoxicity after CAR T-cell therapy: From mechanism to management
    Review

    Rejeski, K.; Jain, M. D.; Shah, N. N.; Perales, M. A.; Subklewe, M.
    The Lancet Haematology (2024)

    Fulltext@MSK | Save
  • Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial
    Journal Article

    Delforge, M.; Patel, K.; Eliason, L.; Dhanda, D.; Shi, L.; Guo, S.; Marshall, T. S.; Arnulf, B.; Cavo, M.; Nooka, A.; more...
    The Lancet Haematology (2024)

    Fulltext@MSK | Save
  • Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: Updated recommendations by the EBMT/ELN International Working Group
    Review

    Kröger, N.; Bacigalupo, A.; Barbui, T.; Ditschkowski, M.; Gagelmann, N.; Griesshammer, M.; Gupta, V.; Hamad, N.; Harrison, C.; Hernandez-Boluda, J. C.; more...
    The Lancet Haematology (2024)

    Fulltext@MSK | Save
  • Residual mutant hematopoietic stem cells drives post-transplant relapse of the myelodysplastic syndromes
    Meeting Abstract

    Kroger, B.; Son, A.; Huang, Y.; Patel, P.; Afrough, A.; Kaur, G.; Anderson, L.; Awan, F.; Ramakrishnan, P.; Verma, K.; more...
    Experimental Hematology (2023)

    Fulltext@MSK | Save
  • Real-world treatment patterns, healthcare resource utilization (HRU) and costs for relapsed/refractory (R/R) large B-cell lymphoma (LBCL): Chimeric antigen receptor T-cell (CAR T) and monoclonal antibodies (MAB) therapies
    Meeting Abstract

    Feng, C.; Murphy, L.; Engel-Nitz, N.; Nguyen, A.; Patel, A.; DuCharme, M.; Fu, C.; Shah, G.
    Value in Health (2023)

    Fulltext@MSK | Save
  • Myocardial composition in light-chain cardiac amyloidosis more than 1 year after successful therapy
    Journal Article

    Cuddy, S. A. M.; Jerosch-Herold, M.; Falk, R. H.; Foley Kijewski, M.; Singh, V.; Ruberg, F. L.; Sanchorawala, V.; Landau, H.; Maurer, M. S.; Yee, A. J.; more...
    JACC: Cardiovascular Imaging (2022)

    Fulltext@MSK | Save
  • Adverse cardiovascular and pulmonary events associated with chimeric antigen receptor T-cell therapy
    Journal Article

    Goldman, A.; Maor, E.; Bomze, D.; Liu, J. E.; Herrmann, J.; Fein, J.; Steingart, R. M.; Mahmood, S. S.; Schaffer, W. L.; Perales, M. A.; more...
    Journal of the American College of Cardiology (2021)

    Fulltext@MSK | Save
  • Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: A single-arm, single-centre, phase 2 trial
    Journal Article

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: An observational cohort study
    Journal Article

    Sharma, A.; Bhatt, N. S.; St Martin, A.; Abid, M. B.; Bloomquist, J.; Chemaly, R. F.; Dandoy, C.; Gauthier, J.; Gowda, L.; Perales, M. A.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save